Calderet in ST Elevation Myocardial Infarction - CASTEMI

Description:

The goal of the trial was to evaluate the efficacy of treatment with caldaret, a novel compound inhibiting calcium overload, compared with placebo in patients with large ST elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI).